Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calzetta

Showing results (81-90 of 459) with videos related to

Pageof 46
Sort By:
Current Opinion in Pharmacology|December 14, 2020
Prospects for severe asthma treatmentLuigino Calzetta, Maria Gabriella Matera, Angelo Coppola, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2016
Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthmaLuigino Calzetta, Barbara Rinaldi, Mario Cazzola, et al.
Expert Review of Respiratory Medicine|February 17, 2018
Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and howLuigino Calzetta, Maria Gabriella Matera, Paola Rogliani, et al.
Expert Opinion on Investigational Drugs|July 5, 2018
Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?Mario Cazzola, Maria Gakriella Matera, Paola Rogliani, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 16, 2025
Multi-Criteria Decision Analysis of Biologics in Chronic Obstructive Pulmonary DiseaseMaria Gabriella Matera, Luigino Calzetta, Paola Rogliani, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 13, 2016
Assessing the viability of long-acting β<sub>2</sub>-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspectiveMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Pharmacogenomics and Personalized Medicine|August 18, 2020
Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for TherapyMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Pharmaceutical Patent Analyst|January 19, 2019
Ensifentrine (RPL554): an inhaled 'bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary diseaseMario Cazzola, Clive Page, Luigino Calzetta, et al.
Pulmonary Therapy|February 7, 2020
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-AnalysesMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 15, 2021
Comparative studies of dual bronchodilation in COPDMario Cazzola, Maria Gabriella Matera, Paola Rogliani, et al.
Pageof 46

Showing results (81-90 of 459) with videos related to

Sort By:
Pageof 46
Current Opinion in Pharmacology|December 14, 2020
Prospects for severe asthma treatmentLuigino Calzetta, Maria Gabriella Matera, Angelo Coppola, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2016
Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthmaLuigino Calzetta, Barbara Rinaldi, Mario Cazzola, et al.
Expert Review of Respiratory Medicine|February 17, 2018
Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and howLuigino Calzetta, Maria Gabriella Matera, Paola Rogliani, et al.
Expert Opinion on Investigational Drugs|July 5, 2018
Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?Mario Cazzola, Maria Gakriella Matera, Paola Rogliani, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 16, 2025
Multi-Criteria Decision Analysis of Biologics in Chronic Obstructive Pulmonary DiseaseMaria Gabriella Matera, Luigino Calzetta, Paola Rogliani, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 13, 2016
Assessing the viability of long-acting β<sub>2</sub>-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspectiveMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Pharmacogenomics and Personalized Medicine|August 18, 2020
Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for TherapyMario Cazzola, Paola Rogliani, Luigino Calzetta, et al.
Pharmaceutical Patent Analyst|January 19, 2019
Ensifentrine (RPL554): an inhaled 'bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary diseaseMario Cazzola, Clive Page, Luigino Calzetta, et al.
Pulmonary Therapy|February 7, 2020
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-AnalysesMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 15, 2021
Comparative studies of dual bronchodilation in COPDMario Cazzola, Maria Gabriella Matera, Paola Rogliani, et al.
Pageof 46